Vaccine Development
Vaccines are among the greatest advancements in public health, and developing new vaccines remains one of the most difficult challenges we face. As vaccine developers achieve important success to control one devastating disease, another pathogen emerges. Your vaccine strategy represents an important blueprint for tackling some of the world’s most deadly and disabling diseases, ensuring science and society work together to protect public health.
At the PPD™ clinical research business of Thermo Fisher Scientific, we apply the expansive global footprint, development capabilities and expertise we’ve built in vaccine development to enable you to attend to the unique needs of vaccine trials and accelerate development with proven solutions and dedicated resources.
Tailored vaccine trial solutions from early development through Phase III
Our global team of therapeutic specialists is fully immersed in the latest advances in vaccine development with expertise in trial design, data analytics, manufacturing, project management, logistics, laboratory testing, pharmacovigilance and regulatory requirements. We combine our extensive therapeutic and laboratory expertise with our global resources to offer world-class vaccine development services.
Our dedicated therapeutic unit for vaccines ensures consistency across assigned study teams and works fast to stay ahead of future public health challenges. We tailor our services across trial populations and phases, for localized or global studies, for biotech and large pharmaceutical companies, and nonprofit and governmental programs. Our footprint extends across six continents — with local expertise in all regions — to apply needed insights for trial approvals, site identification and close oversight during study conduct.
Discover strategies to accelerate speed-to-market and maximize the value of your vaccine.
In the past five years, we have supported:
Vaccine trials
Patients
Global sites
Countries
Contributed to 30+ vaccine licensures in the past 10 years
Committed to driving your program forward
Our global vaccine team comprises more than 2,000 medical, operational and laboratory experts who are dedicated to vaccine clinical trials. The historically low turnover rate among our team members is a testament to their dedication and determination to drive vaccine research — and your programs — forward.
Get to know our therapeutic leaders in vaccine development and hear how they can help move your vaccine program forward
Award-winning vaccine development partner of choice
We are nationally and internationally recognized in the vaccine development landscape. Our awards, recognition and achievements include:
High-quality results through our vaccine sciences labs
Our vaccine sciences lab offers custom immune assay development, clinical testing and submission support services for new, modified and existing vaccines. Our capabilities and more than 25 years of specialized vaccine laboratory experience ensure the development of innovative analytical methods and accurate, high-quality test results to meet your exact needs. We work with clients of all sizes across a wide spectrum of vaccine programs from legacy vaccines to emerging pathogens. Our vast global footprint and expertise with seasonal studies and Northern/Southern hemisphere execution strategies enable rapid deployment of teams to support the staffing needs of vaccine studies, including separate unblinded teams.
Our vaccine sciences lab capabilities
- Priority vaccine sites and networks for rapid site identification and startup
- Timely enrollment, performance guarantees and capacity to support large vaccine efficacy trials, with immunogenicity and disease endpoints
- Operational expertise to deliver pivotal, field-efficacy studies globally and across a range of targeted populations
- Innovative, real-time data technology to support safety trends analysis and decision-making during trial conduct
- Distinct quality control for serology specimens, including cold-chain management, sample logistics and storage facilities with centralized alarm systems to protect serum integrity
- Fully integrated biostatistics group
- Fully electronic system and specialized tools for vaccine assay development, qualification, validation and maintenance to support complex bio functional assays and molecular genomics studies
Paving the way in next-generation vaccine and therapeutics development
The vaccine landscape is continually evolving to explore new modalities and expand therapeutic options for patients. Promising advancements and technical innovations in the mRNA vaccine landscape are paving the way for new therapeutic applications. As a global leader in vaccine clinical development, we understand the complexities of mRNA vaccine and therapeutics development, and we are committed to advancing this vital field.
Watch the webinar to explore advancements in therapeutic vaccine developmentPandemic preparedness and rapid response
Our experience across emergent infectious diseases, including COVID-19, combined with our end-to-end services enable us to achieve accelerated vaccine development timelines. Our agile and flexible model can be adapted to each unique situation to include risk-based monitoring, near real-time access to safety assessments via interactive dashboards, and digitally enabled technologies to conduct low- or no-contact trials. We have deep expertise in regulatory affairs and navigating government contract requirements, enabling us to work in close collaboration with health authorities to avoid unnecessary delays.
Our commitment to urgency
- Global operational teams with pandemic vaccine expertise, enabling us to deploy knowledgeable resources in expedited timeframes
- Statistical and epidemiological modeling to aid trial planning, site selection processes and alignment of demography of study populations
- Global network of Accelerated Enrollment Solutions (AES) sites for vaccine clinical trials with surge capability of up to 3,000 patients per week and experience in emerging disease vaccines
- Integrated PPD™ Laboratory services, including serology, neutralizing antibody and functional assays, as well as peripheral blood mononuclear cells (PBMCs) capabilities
- Digital and decentralized solutions to increase clinical trial access for patients, speed recruitment and support remote/virtual patient follow-up
- Global clinical supplies logistics with integrated cold-chain capabilities and direct-to-patient options
When the worst happens, be sure to have the best by your side
Hear from the very experts who guided our COVID-19 response and why we are uniquely prepared to rapidly mobilize and address future global pandemics
